BCIQ Profiles

Company Profile Report

FDA approves cUTI combo from MDCO

After market close Tuesday, FDA said it approved Vabomere meropenem/vaborbactam from The Medicines Co. (NASDAQ:MDCO) to treat adults

Read the full 184 word article

How to gain access

Continue reading with a
two-week free trial.